IBDEI1LT ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27211,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27211,1,2,0)
 ;;=2^Digoxin up to 0.5 MG
 ;;^UTILITY(U,$J,358.3,27211,1,3,0)
 ;;=3^J1160
 ;;^UTILITY(U,$J,358.3,27212,0)
 ;;=Q0138^^105^1340^9^^^^1
 ;;^UTILITY(U,$J,358.3,27212,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27212,1,2,0)
 ;;=2^Ferumoxytol,Non-ESRD,1 MG
 ;;^UTILITY(U,$J,358.3,27212,1,3,0)
 ;;=3^Q0138
 ;;^UTILITY(U,$J,358.3,27213,0)
 ;;=Q0139^^105^1340^8^^^^1
 ;;^UTILITY(U,$J,358.3,27213,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27213,1,2,0)
 ;;=2^Ferumoxytol,ESRD Use,1 MG
 ;;^UTILITY(U,$J,358.3,27213,1,3,0)
 ;;=3^Q0139
 ;;^UTILITY(U,$J,358.3,27214,0)
 ;;=J1580^^105^1340^10^^^^1
 ;;^UTILITY(U,$J,358.3,27214,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27214,1,2,0)
 ;;=2^Garamycin Gentamicin up to 80 MG
 ;;^UTILITY(U,$J,358.3,27214,1,3,0)
 ;;=3^J1580
 ;;^UTILITY(U,$J,358.3,27215,0)
 ;;=J1644^^105^1340^12^^^^1
 ;;^UTILITY(U,$J,358.3,27215,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27215,1,2,0)
 ;;=2^Heparin Sodium per 1000 Units
 ;;^UTILITY(U,$J,358.3,27215,1,3,0)
 ;;=3^J1644
 ;;^UTILITY(U,$J,358.3,27216,0)
 ;;=96374^^105^1340^13^^^^1
 ;;^UTILITY(U,$J,358.3,27216,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27216,1,2,0)
 ;;=2^IV Push,Ther/Proph/Diag
 ;;^UTILITY(U,$J,358.3,27216,1,3,0)
 ;;=3^96374
 ;;^UTILITY(U,$J,358.3,27217,0)
 ;;=J1750^^105^1340^14^^^^1
 ;;^UTILITY(U,$J,358.3,27217,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27217,1,2,0)
 ;;=2^Iron Dextran 50 MG
 ;;^UTILITY(U,$J,358.3,27217,1,3,0)
 ;;=3^J1750
 ;;^UTILITY(U,$J,358.3,27218,0)
 ;;=B4189^^105^1340^15^^^^1
 ;;^UTILITY(U,$J,358.3,27218,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27218,1,2,0)
 ;;=2^Parenteral NutrSol 10-15 g Protein
 ;;^UTILITY(U,$J,358.3,27218,1,3,0)
 ;;=3^B4189
 ;;^UTILITY(U,$J,358.3,27219,0)
 ;;=J3370^^105^1340^16^^^^1
 ;;^UTILITY(U,$J,358.3,27219,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27219,1,2,0)
 ;;=2^Vancomycin HCL 500 MG
 ;;^UTILITY(U,$J,358.3,27219,1,3,0)
 ;;=3^J3370
 ;;^UTILITY(U,$J,358.3,27220,0)
 ;;=J0882^^105^1340^3^^^^1
 ;;^UTILITY(U,$J,358.3,27220,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27220,1,2,0)
 ;;=2^Darbepoetin Alfa,ESRD Use,1 MCG
 ;;^UTILITY(U,$J,358.3,27220,1,3,0)
 ;;=3^J0882
 ;;^UTILITY(U,$J,358.3,27221,0)
 ;;=J0881^^105^1340^4^^^^1
 ;;^UTILITY(U,$J,358.3,27221,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27221,1,2,0)
 ;;=2^Darbepoetin Alfa,Non-ESRD,1 MCG
 ;;^UTILITY(U,$J,358.3,27221,1,3,0)
 ;;=3^J0881
 ;;^UTILITY(U,$J,358.3,27222,0)
 ;;=J0885^^105^1340^7^^^^1
 ;;^UTILITY(U,$J,358.3,27222,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27222,1,2,0)
 ;;=2^Epoetin Alfa,Non-ESRD,1000 Units
 ;;^UTILITY(U,$J,358.3,27222,1,3,0)
 ;;=3^J0885
 ;;^UTILITY(U,$J,358.3,27223,0)
 ;;=J1642^^105^1340^11^^^^1
 ;;^UTILITY(U,$J,358.3,27223,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27223,1,2,0)
 ;;=2^Heparin Sodium per 10 Units
 ;;^UTILITY(U,$J,358.3,27223,1,3,0)
 ;;=3^J1642
 ;;^UTILITY(U,$J,358.3,27224,0)
 ;;=Q4081^^105^1340^6^^^^1
 ;;^UTILITY(U,$J,358.3,27224,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27224,1,2,0)
 ;;=2^Epoetin Alfa,ESRD Use,1000 Units
 ;;^UTILITY(U,$J,358.3,27224,1,3,0)
 ;;=3^Q4081
 ;;^UTILITY(U,$J,358.3,27225,0)
 ;;=92950^^105^1341^5^^^^1
 ;;^UTILITY(U,$J,358.3,27225,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27225,1,2,0)
 ;;=2^Heart/Lung Resuscitation CPR
 ;;^UTILITY(U,$J,358.3,27225,1,3,0)
 ;;=3^92950
 ;;^UTILITY(U,$J,358.3,27226,0)
 ;;=93224^^105^1341^3^^^^1
 ;;^UTILITY(U,$J,358.3,27226,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,27226,1,2,0)
 ;;=2^ECG Monitor < 48hrs,Intrp & Rpt
